Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)
Is a
Allocation Type
NA
0
Intervention Model
Single Group Assignment
0
Intervention Name
Viralym-C
0
Interventional Trial Phase
Phase 1
0
Interventional Trial Purpose
Treatment
0
Intervention Type
Biological
0
Last Updated
December 26, 2018
0
Masking Type
None (Open Label)
0
Primary Completion Date
2017
0
Trial Recruitment Size
10
0
Trial Sponsor
Clinical Trial Start Date
2015
0
Study Completion Date
2018
0
Clinical Trial Study Type
Interventional
0
NCT Number
Official Name
A Phase I Study Using Most Closely HLA-matched Cytomegalovirus-specific T Lymphocytes for the Treatment of Cytomegalovirus Infections Post-allogeneic Stem Cell Transplant(VIRALYM-C)
0
Official Website
Find more entities like Most Closely Human Leukocyte Antigen (HLA)-Matched CMV-specific T Lymphocytes (Viralym-C)
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.